Location History:
- Bethesda, MA (US) (2020)
- Bethesda, MD (US) (2015 - 2024)
Company Filing History:
22 out of 1,039 
20 out of 3,540 
Years Active: 2015-2025
Title: The Innovative Mind of Aravind Iyer: Transforming Epigenetics through Patents
Introduction: Aravind Iyer, based in Bethesda, MD, is a distinguished inventor boasting an impressive portfolio of 19 patents. His contributions to the field of epigenetics have paved the way for groundbreaking innovations in the regulation and detection of DNA methylation. His work not only propels scientific understanding but also has potential implications in medical research and treatment methodologies.
Latest Patents: Two of Aravind Iyer's latest patents showcase his inventive prowess. The first patent, "Selective oxidation of 5-methylcytosine by TET-family proteins," introduces novel methods for regulating and detecting the cytosine methylation status of DNA. This invention is grounded in the surprising catalytic activity of TET proteins, specifically TET1, TET2, TET3, and CXXC4, which can convert 5-methylcytosine into 5-hydroxymethylcytosine through hydroxylation.
The second patent, "Methods of epigenetic analysis," outlines methods for analyzing epigenetic traits within nucleic acid sequences. The procedures might include sequencing a sample to distinguish hydroxymethylated bases from traditional methylated bases, thus advancing the field of epigenetic research.
Career Highlights: Throughout his career, Aravind has worked with some notable organizations. His experience includes significant roles at Children's Medical Center Corporation and The United States of America, as represented by the Secretary of the Department of Health and Human Services. His work with these institutions has greatly contributed to his expertise and innovative flair in the realm of medical research and biological sciences.
Collaborations: Aravind Iyer has collaborated with esteemed colleagues such as Anjana Rao and Mamta Tahiliani. These partnerships have facilitated a dynamic exchange of ideas and insights, further enriching his inventive process and enhancing the impact of his research.
Conclusion: Aravind Iyer stands out as a significant figure in the innovation landscape of epigenetics. With 19 patents to his name and a focus on the intricate roles of DNA methylation, his work is bound to influence future research and therapeutic strategies. His collaborations and professional engagements reflect a commitment to advancing scientific knowledge, making him a noteworthy inventor in today's world.